Special features of clinical effects of an angiotensin converting enzyme inhibitor lisinopril in patients with arterial hypertension
Britov, A.N.; Alamdarova, I.I.; Deev, A.D.; Orlov, A.A.
Kardiologiia 43(10): 66-71
2003
ISSN/ISBN: 0022-9040 PMID: 14748343 Document Number: 564663
Document emailed within 1 workday
Related Documents
Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40Pavliukova, E.N.; Bakhmet'eva, T.A.; Puzyrev, K.V.; Karpov, R.S. 2006: Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril Kardiologiia 46(9): 19-25
Karlberg, B.E.; Fyhrquist, F.; Grönhagen-Riska, C.; Tikkanen, I.; Ohman, K.P. 1984: Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report Scandinavian Journal of Urology and Nephrology. Supplementum 79: 103-106
Saha, L.; Garg, S.K.; Bhargava, V.K.; Mazumdar, S. 2000: Role of angiotensin-converting enzyme inhibitor, lisinopril, on spermatozoal functions in rats Methods and Findings in Experimental and Clinical Pharmacology 22(3): 159-162
Katel'nitskaia, L.I.; Ivanchenko, D.N.; Khansheva, L.A.; Kholoshina, L.V.; Glova, S.E.; Pleskachev, S.A. 2006: Advantages of long-term controlled stepwise therapy of arterial hypertension with the use of angiotensin converting enzyme inhibitor spirapril Kardiologiia 46(3): 35-38
Al-Omran, M.; Lindsay, T.F. 2005: Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor? Canadian Journal of Cardiology 21(2): 189-193
Karpov, I.A.; Deev, A.D. 2003: Russian study of efficacy and safety of an angiotensin converting enzyme inhibitor quinapril in patients with hypertension Kardiologiia 43(6): 28-32
Mizuno, K.; Hashimoto, S.; Kunii, N.; Tani, M.; Niimura, S.; Yabe, R.; Watari, H.; Fukuchi, S. 1985: Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension Research Communications in Chemical Pathology and Pharmacology 49(2): 175-187
Vladkovs'kyĭ, I.K.; Plesh, I.A.; Haĭdukov, V.A.; Loboda, M.I. 1996: The effect of the angiotensin-converting enzyme inhibitor Capoten on the volume-regulation indices of patients with stage-Ii hypertension Likars'ka Sprava 1996(3-4): 113-117
Schiffrin, E.L.; Deng, L.Y.; Larochelle, P. 1994: Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension Archives des Maladies du Coeur et des Vaisseaux 87(8): 979-981
Moleda, P.; Majkowska, L.; Safranow, K.; Goracy, I.; Adler, G. 2007: I/D polymorphism of angiotensin i converting enzyme gene and arterial hypertension in patients with type 2 diabetes mellitus Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 22(129): 169-172
Aoi, W.; Akahoshi, M.; Takahara, A.; Doi, Y.; Seto, S.; Kusano, E.; Suzuki, S.; Hashida, K.; Takagi, H.; Yoshioka, M. 1985: Effects of angiotensin i converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension Nihon Jinzo Gakkai Shi 27(11): 1571-1583
Stanek, E.J.; Nara, A.R.; Strohl, K.P.; Nair, R.N.; Decker, M.J.; Munger, M.A. 1994: Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure PharmacoTherapy 14(3): 321-329
Zagidullin, N.S.; Valeeva, K.F.; Zagidullin, S.Z.; Rezbaeva, A.G. 2010: Possibilities of the use Angiotensin converting enzyme inhibitor in peripheral arterial disease Kardiologiia 50(4): 92-96
Ryan, E.; Muldowney, F.P. 1983: Use of angiotensin i to Ii converting enzyme inhibitor S.Q. 14225 (captopril), in moderate essential hypertension Irish Medical Journal 76(4): 175; 177-178
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Rosolová, H.; Cech, F.; Sefrna, F. 2002: Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study Vnitrni Lekarstvi 48(8): 701-706
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Salvetti, A.; Pedrinelli, R.; Abdel-Haq, B.; Magagna, A.; Lucarini, A.; Graziadei, L.; Nuccorini, A.; Taddei, S. 1984: Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension Cardiologia 29(1-2): 103-120
Babadzhan, V.D. 2000: Angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension Likars'ka Sprava 2: 19-26